Department of Pathology, Aerospace Center Hospital, Beijing 100049, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jan 28;47(1):35-44. doi: 10.11817/j.issn.1672-7347.2022.210611.
The advanced non-small cell lung cancer (NSCLC) patients with pleural effusion have no opportunity for surgery treatment. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the first-line drugs for these patients with -sensitive mutation. However, the disease progression and drug update during or after treatment of EGFR-TKIs bring more challenges and puzzles to clinical diagnosis and treatment, which inevitably requires archived pleural cell samples for EGFR re-examination or comparative study. Understanding the DNA quality of archived pleural fluid samples and effectively using archival data of pleural fluid cells are of great significance for tracing the origin of cases and basic medical research. This study aims to evaluate the consistency of EGFR mutant gene expression between the 2 methods, and to explore a reliable way for preserving cytological data and making full use of cytological archival data via cell HE staining smear and cell paraffin section.
A total of 57 pleural fluid cytology cases in the Department of Pathology of China Aerospace Center Hospital from October 2014 to April 2021 were selected. Tumor cells were detected by cell HE staining smears and immunohistochemical staining for TTF-1 and Napsin A in the paired cell paraffin sections. There were more than 200 tumor cells in cell HE staining smear and the proportion of tumor cells were ≥70% in matched cell paraffin sections. Patients with 2 cell smears (one for cell data retention and the other for DNA extraction) were selected as the research subjects, and 57 pleural fluid samples were enrolled. gene mutation was detected by amplification refractory mutation system-polymerase chain reaction in 57 paired cell HE staining smears and cell paraffin sections. DNA concentration was 2 ng/μL. Cell HE smear was amplified side-by-side with DNA samples from paired cell paraffin sections. Result determination was according to the requirements of the reagent instructions. The external control cycle threshold (Ct) value of the No. 8 well of the samples to be tested was between 13 and 21, which was considered as successful and reliable samples. When the Ct value of gene mutation was <26, it was considered as positive; when the Ct value was between 26 and 29, it was critical positive; when the Ct value was equal or more than 29, it was negative. ΔCt value was the difference between mutant Ct value and externally controlled Ct value. The smaller the ΔCt value was, the better the quality of DNA of the detected sample was.
Among the 57 pleural effusion samples, 42 patients were hospitalized with pleural effusion as the first symptom, accounting for 73.7% (42/57). mutation was detected in 37 samples [64.9% (37/57)]. The mutation rate for was 37.8% (14/37) while for was 48.6% (18/37). Females were 56.7% (21/37) of mutation cases. The mutation consistency rate of cell HE staining smear and matched cell paraffin sections was 100%. The ΔCt values of cell HE staining smears were less than those of matched cell paraffin sections. The mutation Ct values of 37 cytological samples were statistically analyzed according to the preservation periods of the years of 2014-2015, 2016-2017, 2018-2019, and 2020-2021. There were significant differences in cell paraffin section in the years of 2014-2015 and 2016-2017 compared with the years of 2018-2019 and 2020-2021, while no significant differences were found in cell HE staining smear. Statistical analysis of externally controlled Ct values of 57 cytological samples showed that there were significant differences between cell HE staining smears and cell paraffin section in the years of 2014-2015 and 2016-2017, compared with the years of 2018-2019 and 2020-2021. The mutational Ct values of 37 paired cell blocks and smears were all <26, and the externally controlled Ct values of 57 paired cell paraffin sections and HE staining smears were all between 13 and 21.
The DNA quality of cell HE smears and matched cell paraffin section met the qualified requirements. Two methods possess show an excellent consistency in detecting mutation in NSCLC pleural fluid samples. The DNA quality of cell HE staining smear is better than that of cell paraffin sections, so cell HE staining smear can be used as important supplement of the gene test source. It should be noted that the limitation of cell HE staining smears is non-reproducibility, so multiple smears of pleural fluid are recommended to be prepared for multiple tests.
患有胸腔积液的晚期非小细胞肺癌(NSCLC)患者没有手术治疗的机会。表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)是这些具有 - 敏感突变的患者的一线药物。然而,EGFR-TKI 治疗期间或之后的疾病进展和药物更新给临床诊断和治疗带来了更多的挑战和困惑,这不可避免地需要存档的胸腔细胞样本进行 EGFR 重新检查或比较研究。了解存档胸腔液样本的 DNA 质量,并有效地利用胸腔液细胞的存档数据,对于追踪病例的起源和基础医学研究具有重要意义。本研究旨在评估两种方法之间 EGFR 突变基因表达的一致性,并探索一种可靠的方法,通过细胞 HE 染色涂片和细胞石蜡切片保存细胞学数据并充分利用细胞学存档数据。
选择 2014 年 10 月至 2021 年 4 月期间航天中心医院病理科的 57 例胸腔液细胞学病例,配对的细胞石蜡切片中用细胞 HE 染色涂片和 TTF-1、Napsin A 的免疫组织化学染色检测肿瘤细胞。细胞 HE 染色涂片中的肿瘤细胞超过 200 个,且匹配的细胞石蜡切片中肿瘤细胞的比例≥70%。选择有 2 个细胞涂片(一个用于细胞数据保留,另一个用于 DNA 提取)的患者作为研究对象,共纳入 57 例胸腔液样本。通过扩增受阻突变系统-聚合酶链反应(ARMS-PCR)在 57 个配对的细胞 HE 染色涂片和细胞石蜡切片中检测 基因突变。DNA 浓度为 2ng/μL。细胞 HE 涂片与配对细胞石蜡切片的 DNA 样本同时扩增。结果判定根据试剂说明书的要求进行。待测试样本的第 8 孔的外部对照循环阈值(Ct)值在 13 到 21 之间,被认为是成功和可靠的样本。当 基因突变的 Ct 值<26 时,被认为是阳性;当 Ct 值在 26 到 29 之间时,被认为是临界阳性;当 Ct 值等于或大于 29 时,被认为是阴性。ΔCt 值是突变 Ct 值与外部对照 Ct 值的差异。ΔCt 值越小,检测样本的 DNA 质量越好。
在 57 例胸腔积液样本中,42 例患者以胸腔积液为首发症状入院,占 73.7%(42/57)。[64.9%(37/57)]共检测到 37 例样本的 突变。 突变率为 37.8%(14/37),而 突变率为 48.6%(18/37)。女性为 突变病例的 56.7%(21/37)。细胞 HE 染色涂片和匹配的细胞石蜡切片的突变一致性率为 100%。细胞 HE 染色涂片的 ΔCt 值小于匹配的细胞石蜡切片。根据 2014-2015 年、2016-2017 年、2018-2019 年和 2020-2021 年的保存年限,对 37 例细胞学样本的突变 Ct 值进行统计学分析。2014-2015 年和 2016-2017 年的细胞石蜡切片的突变 Ct 值与 2018-2019 年和 2020-2021 年相比有显著差异,而细胞 HE 染色涂片无显著差异。对 57 例细胞学样本的外部对照 Ct 值进行统计学分析,结果显示 2014-2015 年和 2016-2017 年的细胞 HE 染色涂片和细胞石蜡切片与 2018-2019 年和 2020-2021 年相比有显著差异。37 对配对的细胞块和涂片的突变 Ct 值均<26,57 对配对的细胞石蜡切片和 HE 染色涂片的外部对照 Ct 值均在 13 到 21 之间。
细胞 HE 染色涂片和匹配的细胞石蜡切片的 DNA 质量符合合格要求。两种方法在检测 NSCLC 胸腔积液样本中的 突变时表现出极好的一致性。细胞 HE 染色涂片的 DNA 质量优于细胞石蜡切片,因此细胞 HE 染色涂片可以作为基因检测来源的重要补充。值得注意的是,细胞 HE 染色涂片的局限性在于不可重复性,因此建议制备多个胸腔液涂片进行多次检测。